
August 2022 JASN Highlights: Addressing CKD Progression and Hazards of Intradialytic Hypotension
0:00
8:54
Two highlighted clinical studies: the first addresses the effect of combining a SGLT2 inhibitor and a MRA on proteinuria; the second considers vascular reactivity as a risk factor for cerebral hypoxia when blood pressure falls during dialysis treatments.
D'autres épisodes de "Journal of the American Society of Nephrology (JASN)"
Ne ratez aucun épisode de “Journal of the American Society of Nephrology (JASN)” et abonnez-vous gratuitement à ce podcast dans l'application GetPodcast.